EDITORIAL
HPV vaccine
HPV vaccine: positive insights from universal adolescent HepB vaccination
1 Health Protection Scotland, Glasgow, UK
2 NHS Greater Glasgow and Clyde, Glasgow, UK
3 East Renfrewshire Community Health Care Partnership, Glasgow, UK
Correspondence to:
Dr J Claire Cameron, Epidemiologist (Immunisation), Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, UK; claire.cameron@hps.scot.nhs.uk
The introduction of universal adolescent HPV vaccination in schools has a positive outlook
Abbreviations: HPV, human papillomavirus
| The first 150 words of the full text of this article appear below. |
Preventing cervical cancer by vaccination has become a reality, complementing highly successful screening programmes. One vaccine against human papillomavirus (HPV) is already licensed (Gardasil®, Sanofi Pasteur), and approval for a second (Cervarix®, GSK) is expected shortly. Trials indicate over 90% efficacy in preventing persistent infection with vaccine types (HPV-16 and 18).1 2 In several countries, including the United States, Canada, Australia, Austria, Italy, Germany and France, HPV vaccination has now been universally recommended. Other countries, including the UK, are considering recommendations for its use.
The clinical benefit of HPV vaccines is incontrovertible, and excellent safety profiles have been established. As HPV is a sexually transmitted infection, however, some groups are anxious that vaccination may encourage earlier sexual activity.3 Further, uncertainty about the programmes optimal delivery setting remains.3
However, precedents exist. First, with rubella, against which many countries vaccinated adolescent schoolgirls to protect during later pregnancy, and more recently with
Relevant Article
- In this issue
- Carlos Alvarez-Dardet, John Ashton
J Epidemiol Community Health 2007 61: 1017.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
